Ameritas Investment Partners’s Zentalis Pharmaceuticals ZNTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-5,837
| Closed | -$9.28K | – | 3362 |
|
|
2025
Q1 | $9.28K | Hold |
5,837
| – | – | ﹤0.01% | 2844 |
|
|
2024
Q4 | $17.7K | Hold |
5,837
| – | – | ﹤0.01% | 2684 |
|
|
2024
Q3 | $21.5K | Hold |
5,837
| – | – | ﹤0.01% | 2622 |
|
|
2024
Q2 | $23.9K | Hold |
5,837
| – | – | ﹤0.01% | 2538 |
|
|
2024
Q1 | $92K | Hold |
5,837
| – | – | ﹤0.01% | 1790 |
|
|
2023
Q4 | $88.4K | Hold |
5,837
| – | – | ﹤0.01% | 1822 |
|
|
2023
Q3 | $117K | Buy |
5,837
+1,780
| +44% | +$35.7K | ﹤0.01% | 1540 |
|
|
2023
Q2 | $114K | Buy |
4,057
+376
| +10% | +$10.6K | ﹤0.01% | 1497 |
|
|
2023
Q1 | $63.3K | Hold |
3,681
| – | – | ﹤0.01% | 1827 |
|
|
2022
Q4 | $84.6K | Hold |
3,681
| – | – | ﹤0.01% | 1716 |
|
|
2022
Q3 | $79K | Buy |
3,681
+929
| +34% | +$19.9K | ﹤0.01% | 1671 |
|
|
2022
Q2 | $77K | Hold |
2,752
| – | – | ﹤0.01% | 1686 |
|
|
2022
Q1 | $127K | Hold |
2,752
| – | – | ﹤0.01% | 1481 |
|
|
2021
Q4 | $231K | Hold |
2,752
| – | – | 0.01% | 1142 |
|
|
2021
Q3 | $183K | Buy |
2,752
+145
| +6% | +$9.64K | 0.01% | 1270 |
|
|
2021
Q2 | $139K | Buy |
2,607
+199
| +8% | +$10.6K | 0.01% | 1521 |
|
|
2021
Q1 | $104K | Hold |
2,408
| – | – | ﹤0.01% | 1648 |
|
|
2020
Q4 | $125K | Buy |
2,408
+1,495
| +164% | +$77.6K | 0.01% | 1439 |
|
|
2020
Q3 | $30K | Hold |
913
| – | – | ﹤0.01% | 2171 |
|
|
2020
Q2 | $44K | Buy |
+913
| New | +$44K | ﹤0.01% | 1915 |
|